MinuteCE®

A robust collection of short-form, digestible CE activities that are made to fit into any schedule. With MinuteCE, you’re in control of the content you want, when you want it. To start microlearning, follow these simple steps:

Step 1: Select the episodes & 1-minute challenges you'd like to consume

Step 2: Bank time as you blaze your way through the program

Step 3: Claim credit once available as shown in the Progress Bar

Step 4: Track the status of credits claimed in your profile

Why choose microlearning?

Bite-sized episodes
The most relevant content
Improved retention

To experience MinuteCE for yourself, select one of the episodes below to start learning!

7319

LikeLikedUnlike

Episodes 181-195 of 503

PAD Stage, Risk Assessment & Comorbidities
MinuteCE®
PAD Stage, Risk Assessment & Comorbidities
- Connie N. Hess, MD, MHS
  Peer
1.00 program credits
The Challenge of BCL-2 Resistance in CLL: Treatment Strategies and Emerging Therapies
MinuteCE®
The Challenge of BCL-2 Resistance in CLL: Treatment Strategies and Emerging Therapies
- Thomas Kipps, MD, PhD
  Peer
1.25 program credits
Mutational Testing to Guide Therapy in CLL: Why and When
MinuteCE®
Mutational Testing to Guide Therapy in CLL: Why and When
- Talha Munir, PhD
  Peer
1.25 program credits
Frontline Fixed-Duration Therapy in CLL: Improving Outcomes and Tolerability
MinuteCE®
Frontline Fixed-Duration Therapy in CLL: Improving Outcomes and Tolerability
- Thomas Kipps, MD, PhD
  Peer
- William Wierda, MD, PhD
  Peer
1.25 program credits
Risk-Stratification in Newly Diagnosed CLL
MinuteCE®
Risk-Stratification in Newly Diagnosed CLL
- Thomas Kipps, MD, PhD
  Peer
1.25 program credits
Fixed-Duration Therapy in the Relapsed/Refractory CLL Setting
MinuteCE®
Fixed-Duration Therapy in the Relapsed/Refractory CLL Setting
- Thomas Kipps, MD, PhD
  Peer
- William Wierda, MD, PhD
  Peer
1.25 program credits
MRD Testing to Guide Treatment Considerations in CLL
MinuteCE®
MRD Testing to Guide Treatment Considerations in CLL
- Talha Munir, PhD
  Peer
1.25 program credits
Fixed-Duration vs Continuous-Dosing Approaches in CLL: Impact on QoL and Toxicity Risk
MinuteCE®
Fixed-Duration vs Continuous-Dosing Approaches in CLL: Impact on QoL and Toxicity Risk
- William Wierda, MD, PhD
  Peer
1.25 program credits
MinuteCE®
Fixed-Duration: A Patient-Captivating Standard of Care in CLL
- Talha Munir, PhD
  Peer
- Thomas Kipps, MD, PhD
  Peer
- William Wierda, MD, PhD
  Peer
1.25 credits 10 episodes
Combination Therapy in CLL: Identifying the Right Patient for the Right Treatment Approach
MinuteCE®
Combination Therapy in CLL: Identifying the Right Patient for the Right Treatment Approach
- Thomas Kipps, MD, PhD
  Peer
- William Wierda, MD, PhD
  Peer
1.25 program credits
Overcoming Disease Progression in CLL: Evidence-Based Re-Treatment Considerations
MinuteCE®
Overcoming Disease Progression in CLL: Evidence-Based Re-Treatment Considerations
- Thomas Kipps, MD, PhD
  Peer
- William Wierda, MD, PhD
  Peer
1.25 program credits
Combination Therapy for CLL: What Evidence Do We Have?
MinuteCE®
Combination Therapy for CLL: What Evidence Do We Have?
- William Wierda, MD, PhD
  Peer
1.25 program credits
Strategies to Address Healthcare Disparities in Patients With Endometriosis
MinuteCE®
Strategies to Address Healthcare Disparities in Patients With Endometriosis
- Linda Bradley, MD
  Peer
- Melissa Simon, MD
  Peer
1.75 program credits
Clinical Considerations for the Diagnosis of Endometriosis
MinuteCE®
Clinical Considerations for the Diagnosis of Endometriosis
- Linda Bradley, MD
  Peer
- James A. Simon, MD, CCD, NCMP, IF, FACOG
  Peer
1.75 program credits
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
MinuteCE®
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
  Peer
- James A. Simon, MD, CCD, NCMP, IF, FACOG
  Peer
1.75 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended